Company
Basecamp Research
- AI
- Biotech
- Location:
- London, United Kingdom
- Funding:
- $140M · Series C · Sep 2026
Description
Basecamp Research trains frontier AI models for therapeutic design: its EDEN 28-billion-parameter model, trained on BaseData (>100 billion novel genes), designs gene insertion, gene editing and peptide therapeutics advanced through preclinical development for biopharma partners.
Related
AbridgeAbridge builds an AI assistant that turns clinical conversations into draft and billable documentation for clinicians, nursing teams, and…
Adaptive Biotechnologies ($ADPT)Adaptive Biotechnologies develops immune-system-based diagnostics and data tools, including NGS MRD testing, for clinicians and biopharma…
Age LabsAge Labs develops epigenetic biomarkers and predictive algorithms for early detection of age-related diseases and drug response, providing…
Ångström AIÅngström AI develops diagnostics using amplicon sequencing and machine learning, aiming to broaden access to sequencing-based diagnostic…
APCAPC builds accelerated drug process development services and technologies for small and large pharmaceutical and biotech companies,…
Archangel HealthArchangel Health provide infrastructure software that powers medical artificial intelligence systems, helping healthcare teams operate…
AsimovAsimov designs and delivers integrated cells, genetic constructs, and cloud software to enable commercial-grade cell line and viral vector…
Atlas DiscoveryAtlas Discovery builds autonomous agents to find new disease uses for existing drugs, support more efficient clinical trials, and present…
Atomic AIAtomic AI develops machine-learning and structural-biology tools for RNA drug discovery, supporting RNA-targeted small molecules, RNA-based…
Timeline
Funding Roundbasecamp-research.com ↗
September 23, 2026 DATE PUBLISHED Basecamp Research, a frontier AI company developing AI-designed medicines, today announced a $140M Series C financing The oversubscribed round was led by S32